Netherlands· NL-4220a123d7b4

Visipaque 270 mg I/ml, oplossing voor injectie

A iodixanol product containing jodixanol, registered in Netherlands by GE Healthcare B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC V08AB09

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about jodixanolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Iodixanol is registered in 16 of 19 countries.

Countries holding a registration under ATC V08AB09 (iodixanol), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search iodixanol products by name

Iodixanol · ATC V08AB09

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: JODIXANOL
Manufacturer: GE Healthcare B.V.
Country: Netherlands (NL)
ATC code: V08AB09
ATC class: Iodixanol
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
17664

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

172 interactions on record for iodixanol.

Graded by severity as the source publishes them — 87 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check iodixanol against other medicines How interaction checks work

Iodixanol · interactions on record

172 records

87 severe
50 moderate
35 info

Most severe, free to view

NeomycinA07AA01severe
StreptomycinA07AA04severe
Polymyxin BA07AA05severe
Amphotericin BA07AA07severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Iodixanol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iodixanol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Visipaque
Belgium · Visipaque
Bulgaria · Визипак
Cyprus · Visipaque
Czechia · Visipaque
Germany · Visipaque
Denmark · Visipaque
Estonia · Visipaque
Spain · Visipaque
Finland · Visipaque
France · Visipaque
United Kingdom (Northern Ireland) · Visipaque
Greece · Visipaque
Croatia · Visipaque
Hungary · Visipaque
Ireland · Visipaque Glass Container, Visipaque Polypropylene Container
Iceland · Visipaque
Italy · Visipaque
Lithuania · Visipaque
Luxembourg · Visipaque
Latvia · Visipaque
Malta · Visipaque
Norway · Visipaque
Poland · Visipaque
Portugal · Visipaque
Romania · Visipaque
Sweden · Visipaque
Slovenia · Visipaque
Slovakia · Visipaque

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ffefc98d-c2c1-48d4-9986-e90d53cc6b3c
GET /v1/drugs/ffefc98d-c2c1-48d4-9986-e90d53cc6b3c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intra-arterieel gebruik, Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h17664_smpc.pdf",
  "strength": null,
  "atc_label": "Iodixanol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg17664",
  "excipients": [
    "CALCIUMCHLORIDE 2-WATER (E 509)",
    "DINATRIUMCALCIUMEDETAAT, GEHYDRATEERD (E 385)",
    "NATRIUMCHLORIDE",
    "TROMETAMOL",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "JODIXANOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h17664.pdf",
  "authorised_at": "1995/02/06",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "17664",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about iodixanol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console